Biomarkers in renal cell carcinoma: Towards a more selective immune checkpoint inhibition - ScienceDirect
Comprehensive molecular characterization of clear cell renal cell carcinoma | Nature
Frontiers | The Identification of Immunological Biomarkers in Kidney Cancers
Frontiers | Targeting the Tumor Microenvironment in Renal Cell Cancer Biology and Therapy
A proteogenomic analysis of clear cell renal cell carcinoma in a Chinese population | Nature Communications
Prediction of drug candidates for clear cell renal cell carcinoma using a systems biology-based drug repositioning approach - eBioMedicine
Urine Proteome Profiling Predicts Lung Cancer from Control Cases and Other Tumors - eBioMedicine
Cancers | Free Full-Text | From Immunohistochemistry to New Digital Ecosystems: A State-of-the-Art Biomarker Review for Precision Breast Cancer Medicine
What is a Biomarker? | Lippincott NursingCenter
Mapping the immune environment in clear cell renal carcinoma by single-cell genomics | Communications Biology
Frontiers | Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer
Biomarkers in drug discovery and development
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review: Molecular Therapy - Nucleic Acids
Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma | Journal of Experimental & Clinical Cancer Research
Renal cancer biomarkers: the promise of personalized care | BMC Medicine | Full Text
Biomarkers in renal cell carcinoma: Are we there yet? - ScienceDirect
Synthetic biomarkers: a twenty-first century path to early cancer detection | Nature Reviews Cancer
The Hunt for Urinary Biomarkers to Diagnose Kidney Cancer - Johns Hopkins Medicine
The immunology of renal cell carcinoma | Nature Reviews Nephrology
Kidney Cancer: Recent Advances and Future Directions | Journal of Clinical Oncology
Frontiers | IFI16 Can Be Used as a Biomarker for Diagnosis of Renal Cell Carcinoma and Prediction of Patient Survival
Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma | Journal of Experimental & Clinical Cancer Research
How are biomarkers used to treat cancer? | MD Anderson Cancer Center
Determinants of renal cell carcinoma invasion and metastatic competence | Nature Communications
Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade - ScienceDirect
